Solution Type: Clinical Trial Impact Analysis

Reports that analyze and measure the commercial impact of clinical trial data presented at congresses

Prior to ASCO, Oncologists Were Interested in KEYTRUDA^® for Metastatic CRPC and Advanced NSCLC
KEYTRUDA^® Advanced NSCLC Data are Practice Changing
KEYTRUDA^® Offers The Best Risk-benefit Ratio vs OPDIVO^® And TECENTRIQ^®